de Jesus, Victor Hugo Fonseca
da Costa, Wilson Luiz Jr
Claro, Laura Carolina Lopez
Coimbra, Felipe José Fernandez
Dettino, Aldo Lourenço Abbade
Riechelmann, Rachel P.
Curado, Maria Paula
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RP 160097)
Article History
Received: 13 August 2020
Accepted: 19 February 2021
First Online: 18 March 2021
Competing interests
: Victor Hugo Fonseca de Jesus received honoraria from United Medical and had travel expenses payed by United Medical in the past 12 months. United Medical is the company responsible for the distribution and sale of Nab-Paclitaxel in Brazil. Rachel Pimenta Riechelmann received consultancy fees from Astra Zeneca in the past 12 months. The remaining authors declare no competing interests.